export type Post = {
  slug: string;
  title: string;
  excerpt: string;
  category: string;
  date: string;
  readTime: string;
  content: Section[];
};

export type Section = {
  type: "intro" | "h2" | "h3" | "p" | "ul" | "callout" | "cta" | "disclaimer";
  text?: string;
  items?: string[];
  productSlug?: string;
  vendor?: string;
  affiliateUrl?: string;
};

export const posts: Post[] = [
  {
    slug: "bpc-157-complete-guide",
    title: "BPC-157: The Complete Research Guide",
    excerpt:
      "A deep dive into Body Protection Compound-157 — mechanisms, studied benefits, and what the current literature says.",
    category: "Recovery",
    date: "April 2026",
    readTime: "8 min read",
    content: [
      {
        type: "intro",
        text: "BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a protective protein found in human gastric juice. It has become one of the most widely studied peptides in regenerative research, with a growing body of literature pointing to remarkable tissue-healing properties across multiple systems.",
      },
      {
        type: "h2",
        text: "What Is BPC-157?",
      },
      {
        type: "p",
        text: "BPC-157 is a 15-amino acid sequence (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) first isolated from human gastric juice. Unlike many peptides that target a single pathway, BPC-157 appears to interact with multiple biological systems simultaneously — which may explain its broad range of studied effects.",
      },
      {
        type: "h2",
        text: "Studied Benefits",
      },
      {
        type: "h3",
        text: "1. Tendon & Ligament Repair",
      },
      {
        type: "p",
        text: "Several animal studies have demonstrated accelerated healing of tendon-to-bone injuries with BPC-157 administration. Research published in the Journal of Physiology-Paris showed significant upregulation of growth hormone receptors in tendon fibroblasts, suggesting a direct mechanism for enhanced connective tissue repair.",
      },
      {
        type: "h3",
        text: "2. Gut Health & Mucosal Healing",
      },
      {
        type: "p",
        text: "Given its origin in gastric juice, it's unsurprising that BPC-157 shows strong effects on gastrointestinal tissue. Studies have shown protective effects against NSAID-induced damage, acceleration of intestinal anastomosis healing, and reduction of inflammatory bowel markers. This makes it one of the few peptides with compelling gut-specific research.",
      },
      {
        type: "h3",
        text: "3. Anti-Inflammatory Effects",
      },
      {
        type: "p",
        text: "BPC-157 has demonstrated the ability to modulate nitric oxide (NO) production and downregulate pro-inflammatory cytokines. Multiple studies show reductions in acute inflammation following musculoskeletal injuries in rodent models.",
      },
      {
        type: "h3",
        text: "4. Neurological Support",
      },
      {
        type: "p",
        text: "Emerging research suggests BPC-157 may support dopaminergic and serotonergic system function, with some studies showing neuroprotective effects following traumatic brain injury in animal models.",
      },
      {
        type: "h2",
        text: "Administration Routes Studied",
      },
      {
        type: "ul",
        items: [
          "Subcutaneous injection — most common in research settings",
          "Intramuscular injection — used for localized musculoskeletal studies",
          "Oral/intragastric — studied specifically for gut-related applications",
          "Topical — limited research, mostly for wound healing models",
        ],
      },
      {
        type: "h2",
        text: "What the Research Doesn't Cover",
      },
      {
        type: "p",
        text: "It's important to note that virtually all BPC-157 research to date has been conducted in rodent models. There are no completed human clinical trials as of this writing. While the animal data is consistently compelling, extrapolating these results to human physiology requires caution.",
      },
      {
        type: "callout",
        text: "BPC-157 has not been approved by the FDA for human use. All research on this compound is preclinical. This article is for informational and educational purposes only.",
      },
      {
        type: "h2",
        text: "Where to Source BPC-157 for Research",
      },
      {
        type: "p",
        text: "For legitimate research applications, purity and accurate dosing are critical. We recommend sourcing only from vendors who provide third-party HPLC testing and batch-specific Certificates of Analysis.",
      },
      {
        type: "cta",
        text: "View BPC-157 at Peptide Sciences",
        productSlug: "bpc-157",
        vendor: "Peptide Sciences",
        affiliateUrl: "https://www.peptidesciences.com/bpc-157",
      },
      {
        type: "disclaimer",
        text: "This article contains affiliate links. Aura Protocols may earn a commission if you purchase through these links at no additional cost to you. All compounds are for research use only.",
      },
    ],
  },
  {
    slug: "semaglutide-vs-tirzepatide",
    title: "Semaglutide vs. Tirzepatide: What the Research Shows",
    excerpt:
      "Comparing two of the most researched GLP-1 receptor agonists for body composition and metabolic health.",
    category: "Weight Management",
    date: "March 2026",
    readTime: "7 min read",
    content: [
      {
        type: "intro",
        text: "GLP-1 receptor agonists have fundamentally changed the metabolic research landscape. Semaglutide and tirzepatide are the two most studied compounds in this class — but they work through meaningfully different mechanisms. Here's what the literature actually shows.",
      },
      {
        type: "h2",
        text: "Mechanism of Action",
      },
      {
        type: "h3",
        text: "Semaglutide",
      },
      {
        type: "p",
        text: "Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist. It mimics the endogenous GLP-1 hormone, which is released after eating. Its primary effects include slowing gastric emptying, stimulating insulin secretion in a glucose-dependent manner, and suppressing glucagon release. The net result is reduced appetite, improved glycemic control, and significant reductions in body weight.",
      },
      {
        type: "h3",
        text: "Tirzepatide",
      },
      {
        type: "p",
        text: "Tirzepatide is a dual GIP/GLP-1 receptor agonist — it activates both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the GLP-1 receptor. This dual agonism appears to produce synergistic effects on insulin secretion, fat metabolism, and appetite suppression, which may explain its more pronounced effects in head-to-head comparisons.",
      },
      {
        type: "h2",
        text: "Head-to-Head: What Studies Show",
      },
      {
        type: "ul",
        items: [
          "SURMOUNT-5 trial: Tirzepatide produced ~20% greater weight loss than semaglutide in people with obesity",
          "Semaglutide (STEP trials): Average 15–17% body weight reduction over 68 weeks",
          "Tirzepatide (SURMOUNT trials): Average 20–22% body weight reduction over 72 weeks",
          "Both show significant cardiovascular risk reduction in large outcome trials",
          "Tirzepatide shows stronger HbA1c reduction in T2D populations",
        ],
      },
      {
        type: "h2",
        text: "Side Effect Profiles",
      },
      {
        type: "p",
        text: "Both compounds share a similar GI side effect profile — nausea, vomiting, and diarrhea are the most commonly reported, particularly during dose escalation. These effects typically diminish over time. Tirzepatide's GIP activity may modulate some of the GI tolerability seen with pure GLP-1 agonists, though clinical differences are modest.",
      },
      {
        type: "h2",
        text: "Which Is Right for Research?",
      },
      {
        type: "p",
        text: "The choice between semaglutide and tirzepatide for research purposes depends on the specific question being studied. Semaglutide has a longer research track record and more published data. Tirzepatide represents the current frontier of dual-agonist research and shows greater magnitude of effect in weight-focused studies.",
      },
      {
        type: "callout",
        text: "Neither semaglutide nor tirzepatide is approved for general use outside of specific medical indications. Research applications require appropriate institutional oversight.",
      },
      {
        type: "cta",
        text: "View Semaglutide at Core Peptides",
        productSlug: "semaglutide",
        vendor: "Core Peptides",
        affiliateUrl: "https://corepeptides.com/semaglutide",
      },
      {
        type: "disclaimer",
        text: "This article contains affiliate links. Aura Protocols may earn a commission if you purchase through these links at no additional cost to you. All compounds are for research use only.",
      },
    ],
  },
  {
    slug: "cjc-1295-ipamorelin-stack",
    title: "CJC-1295 / Ipamorelin Stack: Growth Hormone Optimization",
    excerpt:
      "Why this combo has become the gold standard for GH-axis support in research settings.",
    category: "Growth & Performance",
    date: "March 2026",
    readTime: "6 min read",
    content: [
      {
        type: "intro",
        text: "Among growth hormone secretagogue combinations, CJC-1295 paired with Ipamorelin has emerged as one of the most researched and consistently cited stacks. The synergy between these two compounds — one a GHRH analogue, the other a selective ghrelin mimetic — produces robust, pulsatile GH release with a favorable safety profile compared to exogenous GH administration.",
      },
      {
        type: "h2",
        text: "Understanding Each Compound",
      },
      {
        type: "h3",
        text: "CJC-1295 (with DAC)",
      },
      {
        type: "p",
        text: "CJC-1295 is a synthetic analogue of growth hormone-releasing hormone (GHRH). The DAC (Drug Affinity Complex) modification extends its half-life from minutes to approximately 6–8 days by binding to serum albumin. This produces sustained elevation of baseline GH and IGF-1 levels rather than sharp pulses.",
      },
      {
        type: "h3",
        text: "Ipamorelin",
      },
      {
        type: "p",
        text: "Ipamorelin is a selective growth hormone secretagogue and ghrelin receptor agonist (GHSR). It is notable for its high selectivity — it stimulates GH release without significantly elevating cortisol or prolactin, which distinguishes it from older GH secretagogues like GHRP-2 and GHRP-6.",
      },
      {
        type: "h2",
        text: "Why the Combination Works",
      },
      {
        type: "p",
        text: "CJC-1295 and Ipamorelin act on two distinct receptors within the GH axis — GHRH receptors and ghrelin receptors respectively. When combined, they produce a synergistic amplification of GH pulse amplitude. Research suggests the combination produces GH release 2–10x greater than either compound alone, while maintaining the physiological pulsatile pattern that exogenous GH disrupts.",
      },
      {
        type: "ul",
        items: [
          "CJC-1295 raises the baseline 'floor' of GH secretion",
          "Ipamorelin amplifies individual GH pulses",
          "Combined effect: higher amplitude pulses on an elevated baseline",
          "Preserves natural GH rhythm unlike exogenous HGH",
          "No significant cortisol or prolactin elevation (Ipamorelin selective)",
        ],
      },
      {
        type: "h2",
        text: "Studied Effects",
      },
      {
        type: "ul",
        items: [
          "Increased lean body mass in multiple animal models",
          "Reduction in adipose tissue, particularly visceral fat",
          "Improved sleep quality (GH is primarily secreted during slow-wave sleep)",
          "Enhanced recovery from exercise-induced muscle damage",
          "Improved bone mineral density markers in aging models",
        ],
      },
      {
        type: "callout",
        text: "CJC-1295 and Ipamorelin are research compounds only. They have not been approved by the FDA for human use. All referenced effects are from preclinical studies.",
      },
      {
        type: "cta",
        text: "View CJC-1295 / Ipamorelin at Limitless Life Nootropics",
        productSlug: "cjc-1295-ipamorelin",
        vendor: "Limitless Life Nootropics",
        affiliateUrl: "https://limitlesslifenootropics.com/cjc-1295-ipamorelin",
      },
      {
        type: "disclaimer",
        text: "This article contains affiliate links. Aura Protocols may earn a commission if you purchase through these links at no additional cost to you. All compounds are for research use only.",
      },
    ],
  },
  {
    slug: "best-peptides-for-weight-loss",
    title: "Best Peptides for Weight Loss: What the Research Shows",
    excerpt:
      "A research-backed breakdown of the most studied peptides for fat loss, appetite control, and metabolic optimization.",
    category: "Weight Management",
    date: "April 2026",
    readTime: "9 min read",
    content: [
      {
        type: "intro",
        text: "The peptide space has produced some of the most compelling weight management research in recent history. From GLP-1 receptor agonists to growth hormone secretagogues, several compounds have demonstrated significant fat loss effects in controlled studies. Here's what the evidence actually shows.",
      },
      {
        type: "h2",
        text: "1. Semaglutide — The Benchmark",
      },
      {
        type: "p",
        text: "Semaglutide remains the most clinically studied peptide for weight loss. As a GLP-1 receptor agonist, it works by slowing gastric emptying, reducing appetite signals in the hypothalamus, and improving insulin sensitivity. The STEP trials showed an average of 15–17% body weight reduction over 68 weeks — results previously unseen outside of bariatric surgery.",
      },
      {
        type: "ul",
        items: [
          "15–17% average body weight reduction in STEP clinical trials",
          "Significant reduction in waist circumference and visceral fat",
          "Improved fasting glucose and HbA1c",
          "Cardiovascular risk reduction in SELECT trial",
        ],
      },
      {
        type: "cta",
        text: "View Semaglutide at Core Peptides",
        productSlug: "semaglutide",
        vendor: "Core Peptides",
        affiliateUrl: "https://corepeptides.com/semaglutide",
      },
      {
        type: "h2",
        text: "2. CJC-1295 / Ipamorelin — Indirect Fat Loss via GH",
      },
      {
        type: "p",
        text: "Growth hormone has well-documented lipolytic effects — it directly stimulates the breakdown of stored fat (lipolysis) and inhibits fat storage. CJC-1295 paired with Ipamorelin produces sustained, physiological GH elevation that supports fat metabolism, particularly visceral and subcutaneous adipose tissue reduction.",
      },
      {
        type: "ul",
        items: [
          "GH-mediated lipolysis — direct fat cell breakdown",
          "Preferential loss of visceral fat in animal models",
          "Preservation of lean muscle mass during caloric restriction",
          "Improved insulin sensitivity over time",
        ],
      },
      {
        type: "cta",
        text: "View CJC-1295 / Ipamorelin at Limitless Life Nootropics",
        productSlug: "cjc-1295-ipamorelin",
        vendor: "Limitless Life Nootropics",
        affiliateUrl: "https://limitlesslifenootropics.com/cjc-1295-ipamorelin",
      },
      {
        type: "h2",
        text: "3. BPC-157 — Supporting the Metabolic Environment",
      },
      {
        type: "p",
        text: "While BPC-157 is not a direct fat loss compound, its role in gut healing and metabolic regulation deserves mention in weight management research. Gut microbiome health and intestinal barrier integrity are increasingly recognized as critical factors in metabolic health and body composition. BPC-157's documented effects on gut mucosal healing may support an optimal metabolic environment.",
      },
      {
        type: "h2",
        text: "Stacking Considerations",
      },
      {
        type: "p",
        text: "Research contexts often combine compounds with complementary mechanisms. A GLP-1 agonist like semaglutide addresses appetite and insulin signaling, while a GH secretagogue stack addresses direct lipolysis and muscle preservation. These are distinct pathways that can theoretically be studied in combination — though this requires careful protocol design.",
      },
      {
        type: "callout",
        text: "All peptides discussed in this article are research compounds only. They are not approved for weight loss treatment and must not be used as substitutes for medical care. Consult a qualified physician for any weight management concerns.",
      },
      {
        type: "disclaimer",
        text: "This article contains affiliate links. Aura Protocols may earn a commission if you purchase through these links at no additional cost to you. All compounds are for research use only.",
      },
    ],
  },
  {
    slug: "peptides-for-libido-sexual-health",
    title: "Peptides for Libido & Sexual Health: PT-141 and Beyond",
    excerpt:
      "An evidence-based look at peptides studied for libido enhancement and sexual function in both men and women.",
    category: "Wellness",
    date: "April 2026",
    readTime: "7 min read",
    content: [
      {
        type: "intro",
        text: "Sexual health is a dimension of wellness that is increasingly being studied through the lens of peptide biology. Unlike traditional approaches that target hormones or vascular function, several peptides operate through central nervous system pathways — specifically the melanocortin system — to influence libido and sexual response at the neurological level.",
      },
      {
        type: "h2",
        text: "PT-141 (Bremelanotide) — The Most Studied",
      },
      {
        type: "p",
        text: "PT-141 is a synthetic analogue of alpha-melanocyte-stimulating hormone (α-MSH) and acts as a melanocortin receptor agonist — specifically at MC3R and MC4R receptors in the central nervous system. Unlike PDE5 inhibitors (sildenafil, tadalafil) which work primarily through vascular mechanisms, PT-141 activates the neural pathways that initiate sexual desire.",
      },
      {
        type: "ul",
        items: [
          "Acts centrally via melanocortin receptors — not vascular",
          "Studied in both male and female sexual dysfunction models",
          "FDA approved version (Vyleesi) exists for hypoactive sexual desire disorder in premenopausal women",
          "Shown to increase sexual desire and arousal independent of hormonal status",
          "Effects reported within 45–60 minutes in clinical studies",
        ],
      },
      {
        type: "h3",
        text: "Research in Women",
      },
      {
        type: "p",
        text: "PT-141 has been studied in women with hypoactive sexual desire disorder (HSDD). Double-blind trials demonstrated statistically significant improvements in sexual desire scores compared to placebo. The central mechanism of action makes it particularly relevant for desire-phase dysfunction, which is distinct from arousal or physiological response issues.",
      },
      {
        type: "h3",
        text: "Research in Men",
      },
      {
        type: "p",
        text: "In men, PT-141 has been studied both as a standalone compound and in combination with PDE5 inhibitors. Research shows improvements in erectile function scores, with the central pathway providing benefit even in cases where vascular approaches are insufficient. The dual mechanism — central desire activation plus possible peripheral effects — makes it a distinctive research subject.",
      },
      {
        type: "cta",
        text: "View PT-141 at Swiss Chems",
        productSlug: "pt-141",
        vendor: "Swiss Chems",
        affiliateUrl: "https://swisschems.is/product/pt-141",
      },
      {
        type: "h2",
        text: "The Role of BPC-157 in Sexual Health",
      },
      {
        type: "p",
        text: "BPC-157's nitric oxide modulating properties have generated interest in its potential role in vascular aspects of sexual function. Nitric oxide is a key mediator of penile erection and clitoral engorgement. While direct sexual health studies on BPC-157 are limited, its effects on NO pathways and vascular health represent an emerging area of research interest.",
      },
      {
        type: "h2",
        text: "Hormonal Context: Sermorelin and Testosterone",
      },
      {
        type: "p",
        text: "Growth hormone and IGF-1 play supporting roles in sexual health — they influence energy, mood, and hormonal balance. Sermorelin, as a GHRH analogue, stimulates natural GH production and has been studied in the context of age-related hormonal decline. In men with low GH status, restoration of GH levels has been associated with improvements in sexual function markers.",
      },
      {
        type: "h2",
        text: "Key Considerations for Researchers",
      },
      {
        type: "ul",
        items: [
          "PT-141 is the most directly studied peptide for sexual function",
          "Central vs. peripheral mechanisms are an important distinction in study design",
          "Hormonal baseline (testosterone, estrogen, GH) should be characterized in any study",
          "Nausea is the most commonly reported side effect of PT-141 in clinical trials",
          "Flushing and transient blood pressure changes have been observed at higher doses",
        ],
      },
      {
        type: "callout",
        text: "All compounds discussed are for research purposes only. Sexual health concerns should be addressed with a qualified healthcare professional. PT-141 (Vyleesi) is FDA-approved only for a specific indication in premenopausal women under medical supervision.",
      },
      {
        type: "disclaimer",
        text: "This article contains affiliate links. Aura Protocols may earn a commission if you purchase through these links at no additional cost to you. All compounds are for research use only.",
      },
    ],
  },
  {
    slug: "how-to-read-a-peptide-coa",
    title: "How to Read a Peptide Certificate of Analysis",
    excerpt:
      "A plain-English breakdown of what's in a COA, what to look for, and red flags to avoid.",
    category: "Buyer's Guide",
    date: "February 2026",
    readTime: "5 min read",
    content: [
      {
        type: "intro",
        text: "A Certificate of Analysis (COA) is the single most important document when evaluating a peptide vendor. It's the paper trail between a manufacturer's claims and independent verification. Yet most buyers don't know how to read one. This guide breaks it down.",
      },
      {
        type: "h2",
        text: "What a COA Should Include",
      },
      {
        type: "ul",
        items: [
          "Product name and lot/batch number",
          "Testing laboratory name and accreditation (look for ISO 17025)",
          "Test date (should be recent — within 12 months of purchase)",
          "HPLC purity result (High-Performance Liquid Chromatography)",
          "Mass spectrometry (MS) confirmation of molecular identity",
          "Amino acid composition or sequence confirmation",
          "Moisture content and residual solvent analysis (for lyophilized peptides)",
        ],
      },
      {
        type: "h2",
        text: "The Most Important Number: HPLC Purity",
      },
      {
        type: "p",
        text: "HPLC purity tells you what percentage of the sample is actually the peptide you ordered. Everything else is impurities — which could be related peptide fragments, synthesis byproducts, or in worst cases, entirely different compounds.",
      },
      {
        type: "ul",
        items: [
          "≥99% purity — pharmaceutical grade, ideal for sensitive research",
          "≥98% purity — research grade, acceptable for most applications",
          "95–98% purity — lower grade, use with caution",
          "Below 95% — do not use for any serious research application",
        ],
      },
      {
        type: "h2",
        text: "Mass Spectrometry: Confirming Identity",
      },
      {
        type: "p",
        text: "HPLC tells you how pure the sample is, but mass spectrometry (MS) tells you what it actually is. A COA with both HPLC and MS data is significantly more trustworthy than one with HPLC alone. Look for the reported molecular weight to match the theoretical molecular weight of the compound within a small margin (typically ±0.5 Da).",
      },
      {
        type: "h2",
        text: "Red Flags to Watch For",
      },
      {
        type: "ul",
        items: [
          "No third-party lab — in-house testing only means the vendor is grading their own work",
          "No lab name or accreditation on the COA",
          "COA older than 18 months — peptides degrade, testing should be recent",
          "Purity reported without a specific method (HPLC, MS, etc.)",
          "Generic COA not tied to a specific batch number",
          "COA available only on request — reputable vendors post them publicly",
        ],
      },
      {
        type: "h2",
        text: "How Aura Protocols Vets Vendors",
      },
      {
        type: "p",
        text: "Every vendor we feature on Aura Protocols must provide publicly accessible, batch-specific COAs from accredited third-party laboratories. We manually review these documents before listing any product. If a vendor's documentation doesn't meet our standards, they don't appear on this site — regardless of commission rates.",
      },
      {
        type: "callout",
        text: "When in doubt, email the vendor and ask for the COA for the specific batch you're purchasing. A trustworthy vendor will respond promptly with complete documentation.",
      },
      {
        type: "disclaimer",
        text: "This article contains affiliate links. Aura Protocols may earn a commission if you purchase through these links at no additional cost to you. All compounds are for research use only.",
      },
    ],
  },
];
